March 8, 2026 - 04:53

With the release of its fourth-quarter results, Oscar Health has provided a clearer roadmap to achieving its long-promised goal of profitability. Chief Executive Mark Bertolini has consistently pointed to 2026 as the pivotal year, and the latest financial data underscores the strategic bets the insurer is making to reach that milestone.
The company's recent quarterly performance presented a mixed picture, with some headline figures appearing challenging. However, the underlying strategy focuses on disciplined growth and operational efficiency. Central to this plan is a continued shift toward higher-margin insurance products and a deeper investment in proprietary technology platforms designed to streamline care coordination and administrative costs.
Bertolini's confidence is rooted in a targeted expansion within the Medicare Advantage sector and the individual Affordable Care Act marketplace, where Oscar believes its tech-driven model provides a distinct advantage. The emphasis is on sustainable, measured growth in these specific segments rather than pursuing market share at any cost. By leveraging data analytics and member engagement tools, the company aims to improve health outcomes while carefully managing medical expenses.
The path to 2026 will require consistent execution, but Oscar Health's leadership asserts that the foundational elements are now in place. The coming years will test whether this focused approach can finally translate the company's innovative model into sustained financial success.
April 22, 2026 - 01:51
WATCH: Axios Future of Health Summit 2026A major virtual gathering this week will convene leading experts to examine the transformative trends shaping medicine. The event focuses on the critical innovations and policies expected to define...
April 21, 2026 - 01:32
Former LSU QB has some health concerns leading into the draftAs the NFL Draft approaches, medical evaluations are taking center stage, with one prominent prospect facing increased scrutiny. The former LSU quarterback, widely regarded for his elite collegiate...
April 20, 2026 - 08:00
Blockbuster GLP-1 Diabetes and Weight Loss Drugs Fails in Alzheimer’s TrialA much-anticipated clinical trial investigating the potential of a blockbuster GLP-1 drug to slow the progression of Alzheimer`s disease has failed to meet its primary goal. The study focused on...
April 19, 2026 - 20:41
Trump signs order to expand access to psychedelic treatments for mental health conditionsIn a significant shift for mental health treatment, the executive branch has directed federal agencies to explore the therapeutic potential of psychedelic substances. A newly signed directive...